Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.

Slides:

Advertisements

Similar presentations

ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.

Advertisements

Role of MRSA Swabs for De-escalation of Antibiotics in HCAP

Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.

HAP and VAP Guidelines Update

Nosocomial Antibiotic Resistant Organisms

MRSA Learning Objectives:

Clinical Microbiology and Infection

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

Volume 139, Issue 5, Pages (May 2011)

ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.

Prevention: The Answer for Bacterial Resistance

The challenges of multi-drug-resistance in hepatology

A) IS6110 restriction fragment length polymorphism (RFLP) and b) spoligotyping patterns of a multidrug-resistant tuberculosis (MDR-TB) cluster. a) IS6110.

Clinical Microbiology and Infection

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Clinical impact of antibiotic-resistant Gram-positive pathogens

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis.

A) CT scan of patient number 1, before pembrolizumab; b) CT scan of patient number 1, after 11 pembrolizumab infusions; c) CT scan of patient number 1,

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Appropriate vs. inappropriate antimicrobial therapy

Treatment of staphylococcal infections with cyclic lipopeptides

MRSA=Methicillin resistant Staphylococcus aureus

Targeted antibiotic management of ventilator-associated pneumonia

G. Höffken Clinical Microbiology and Infection

Bacterial resistance—the clinical challenge

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini,

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Strategies for managing today's infections

Swimmer plots showing post-nivolumab progression-free survival for the three main drugs studied according to the line of treatment in which they were received.

Percentage of previously treated tuberculosis (TB) cases with multidrug-resistant (MDR)-TB. Percentage of previously treated tuberculosis (TB) cases with.

Levofloxacin in the treatment of ventilator-associated pneumonia

M. Aires-de-Sousa Clinical Microbiology and Infection

Spread of Staphylococcus aureus clinical isolates carrying Panton–Valentine leukocidin genes during a 3-year period in Greece V. Chini, E. Petinaki,

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.

Summary of the specialist nurse coordinated multidisciplinary team (MDT) pathway at University Hospital Southampton Foundation Trust, Southampton, UK.

Can β-lactams be re-engineered to beat MRSA?

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Evolving problems with resistant pathogens

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

a) Mortality per time point (p<0

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

E. Tacconelli Clinical Microbiology and Infection

A family-based pulmonary rehabilitation (PR) programme enhanced the coping resources of the families of chronic obstructive pulmonary disease patients.

A. Manzur, F. Gudiol Clinical Microbiology and Infection

W. Witte Clinical Microbiology and Infection

A)Standardised mortality ratios for chronic bronchitis in men and women (1968–1978) and b) infant mortality from bronchitis and pneumonia per 1000 births.

B.A. Cunha Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Concordance of review article recommendations with contemporary guidelines. Concordance of review article recommendations with contemporary guidelines.

Number of ventilator-associated pneumonia (VAP) patients with newly isolated micro-organisms from endotracheal aspirates after initiation of antibiotic.

Weekly pneumococcal community-acquired pneumonia incidence rates over 5 years, with delineated school holiday periods by year. a) Year 1 (September 2008–2009).

Duration of antibiotic therapy according to clinical pulmonary infection score in a randomised trial of an antibiotic discontinuation policy for clinically.

All microorganism strains isolated from the sputum during the study period. All microorganism strains isolated from the sputum during the study period.

Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

J. Segreti Clinical Microbiology and Infection

Fighting MDR G-Negative Infections

Composition of the most common clusters at the a) onset of the first acute respiratory tract infection (swab A) and b) 3 weeks later (swab B) illustrated.

Outcomes of infections caused by carbapenemase-producing Klebsiella pneumoniae, according to treatment regimen. Outcomes of infections caused by carbapenemase-producing.

Prevalence of acute myocardial infarction (AMI) or other cardiovascular events (CVEs) according to a) Pneumonia Severity Index (PSI) risk classes and b)

Biomarker levels at hospital admission, clinical stabilisation and 6-week follow-up in 267 hospitalised patients with community-acquired pneumonia. a)

Compliance with empiric therapy guidelines for treatment of each type of pneumonia. Compliance with empiric therapy guidelines for treatment of each type.

Presentation transcript:

Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). MDR: multidrug-resistant; ICU: intensive care unit; MRSA: methicillin-resistant Staphylococcus aureus. #: low risk for mortality is defined as a ≤15% chance of dying, a mortality rate that has been associated with better outcomes using monotherapy than combination therapy when treating serious infection [18]. Reproduced from [2]. Antoni Torres et al. ERJ Open Res 2018;4:00028-2018 ©2018 by European Respiratory Society